- Home
- PHR
PHR
Phreesia Inc.
as 10-03-2025 4:00pm EST
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | WILMINGTON |
| Market Cap: | 1.6B | IPO Year: | 2019 |
| Target Price: | $33.47 | AVG Volume (30 days): | 1.0M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 15 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.42 | EPS Growth: | N/A |
| 52 Week Low/High: | $17.07 - $32.76 | Next Earning Date: | 09-04-2025 |
| Revenue: | $449,672,000 | Revenue Growth: | 15.31% |
| Revenue Growth (this year): | 14.97% | Revenue Growth (next year): | 12.12% |
Stock Insider Trading Activity of Phreesia Inc. (PHR)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Linetsky David | PHR | President, Network Solutions | Sep 18 '25 | Sell | $23.94 | 93 | $2,226.30 | 9,883 | |
| Linetsky David | PHR | President, Network Solutions | Sep 17 '25 | Sell | $23.50 | 1,064 | $25,004.00 | 9,883 | |
| Hoffman Allison C | PHR | General Counsel & Secretary | Sep 17 '25 | Sell | $23.50 | 2,059 | $48,386.50 | 136,978 | |
| VanDuyn Amy Beth | PHR | SVP, Human Resources | Sep 16 '25 | Sell | $23.28 | 1,762 | $41,027.11 | 112,479 | |
| Roberts Evan | PHR | President, Provider Solutions | Sep 16 '25 | Sell | $23.28 | 3,761 | $87,572.63 | 726,837 | |
| Linetsky David | PHR | President, Network Solutions | Sep 16 '25 | Sell | $23.28 | 2,165 | $50,410.73 | 9,883 | |
| Hoffman Allison C | PHR | General Counsel & Secretary | Sep 16 '25 | Sell | $23.28 | 3,133 | $72,950.03 | 136,978 | |
| Indig Chaim | PHR | Chief Executive Officer | Sep 16 '25 | Sell | $23.28 | 6,328 | $147,343.68 | 1,255,771 | |
| Gandhi Balaji | PHR | Chief Financial Officer | Sep 16 '25 | Sell | $23.28 | 4,183 | $97,398.65 | 99,125 | |
| Hui Yvonne | PHR | Principal Accounting Officer | Sep 16 '25 | Sell | $23.28 | 940 | $21,887.34 | 30,638 |
Latest Phreesia Inc. News
PHR Breaking Stock News: Dive into PHR Ticker-Specific Updates for Smart Investing
Simply Wall St.
a month ago
Phreesia Second Quarter 2026 Earnings: EPS Beats Expectations
GuruFocus.com
a month ago
Phreesia Inc (PHR) Q2 2026 Earnings Call Highlights: Record Revenue and First Positive Net Income
Motley Fool
a month ago
Phreesia PHR Q2 2026 Earnings Call Transcript
Zacks
a month ago
Phreesia (PHR) Reports Q2 Earnings: What Key Metrics Have to Say
Zacks
a month ago
Phreesia (PHR) Q2 Earnings and Revenues Beat Estimates
Associated Press Finance
a month ago
Phreesia: Fiscal Q2 Earnings Snapshot
MT Newswires
a month ago
Phreesia Swings to Q2 Earnings, Revenue Increases; Plans to Acquire AccessOne in $160 Million Deal
Business Wire
a month ago
Phreesia Announces Second Quarter Fiscal 2026 Results
Compare PHR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PHR Phreesia Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.